tumor expansion trial
Scope
Date
~
-
Chief Executives
Samsung Biologics CEO focuses on global business
John Rim, chief executive of Samsung BioLogics will directly lead his company's global sales operations for biopharmaceuticals through contract deve...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Inventage Lab launches clinical trials for addiction treatment in Australia
South Korea's Inventage Lab, a developer of a drug delivery system platform, on Wednesday said it received approval from the Human Research Ethics C...
Jan 26, 2023 (Gmt+09:00)
-
Beauty & Cosmetics
Kolmar Korea to establish new cosmetics production base in Sejong City
South Korea's cosmetic original design manufacturer Kolmar Korea said Wednesday that it would establish a cosmetics production base equipped with ar...
Jan 25, 2023 (Gmt+09:00)
-
Bio & Pharma
NGeneBio's diagnostic products start to be used in clinical tests in Vietnam
South Korea's medical diagnostics company NGeneBio Co. said on Wednesday that it is expanding its business in the Southeast Asian precision diagnost...
Jan 19, 2023 (Gmt+09:00)
-
Banking & Finance
BC Card eyes Central Asian payment market entry this year
South Korea's financial services company BC Card said on Wednesday that it would seek to enter the Central Asian market this year on the back of its...
Jan 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Medipost completes first dose of Cartistem in phase 3 clinical trials in Japan
South Korea's stem cell research company Medipost Co. said on Monday that it has completed the administration of Cartistem, a stem cell treatment fo...
Jan 17, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Biomedics gets approval for Parkinson's disease clinical trials
South Korea's biomedicine firm S.Biomedics said on Friday that it has won approval from the Ministry of Food and Drug Safety for phase 1 and 2a clin...
Jan 13, 2023 (Gmt+09:00)
-
Bio & Pharma
SK bio families to present visions to global investors at SK Bio Night
SK Inc., the investment company of SK Group, said on Tuesday that it will hold a networking event called "SK Bio Night" in the US along with its bio...
Jan 10, 2023 (Gmt+09:00)
-
Bio & Pharma
GCCL develops Korea's first automatic clinical trial data sharing system
Global Clinical Central Lab (GCCL), an affiliate of South Korean pharmaceutical firm Green Cross Corp., said on Monday it has jointly developed Kore...
Jan 10, 2023 (Gmt+09:00)
-
Korean Innovators at CES 2023
LG Elec to increase partnerships for business expansion
LAS VEGAS -- LG Electronics Inc., the world’s top home appliance maker, is seeking more partnerships with global leading companies and increas...
Jan 05, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB confirms ophthalmic disease treatment in phase 3 clinical trials
South Korea’s biomedicine startup HLB Therapeutics Co. said on Monday that its Neurotrophic Keratopathy (NK) treatment RGN-259 proved effectiv...
Jan 03, 2023 (Gmt+09:00)
-
Venture capital
Document tool company Business Canvas secures Series A2 round
Business Canvas, a South Korean SaaS (software as a service) startup that services the global document tool "Typed," announced on Tuesday that it ha...
Jan 02, 2023 (Gmt+09:00)
-
Bio & Pharma
GI Cell wins approval for human cell management from Korean regulator
GI Cell, a South Korean developer of immune cell therapy products, received a human cell and others management license from South Korean regulatory,...
Dec 27, 2022 (Gmt+09:00)
-
Bio & Pharma
CJ applies to FDA for trials of immuno-anticancer drug candidate
CJ Bioscience, an independent red bio (pharmaceutical and healthcare) subsidiary of CJ CheilJedang Corp., said on Monday it has submitted a phase 1 ...
Dec 26, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for FDA approval for Remsima SC
Celltrion Ltd. said on Friday it had applied the previous day for permission from the US Food and Drug Administration (FDA) for Remsima SC, an autoi...
Dec 23, 2022 (Gmt+09:00)
-
Bio & Pharma
JW Pharma applies for phase 3 trial in Taiwan for gout treatment
JW Pharmaceutical announced through its disclosure on Monday that it had applied last Friday for a phase 3 trial for Epaminurad, a gout treatment, w...
Dec 19, 2022 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma confirms safety of flu vaccine in phase 1 trial
South Korea's leading pharmaceutical company GC Biopharma Corp. said on Thursday that it has confirmed the safety and immunogenicity of the patch-ty...
Dec 15, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm begins clinical trials of wearable device for detecting epilepsy
SK Group's new drug development subsidiary SK Biopharmaceuticals Co. will begin clinical trials for a wearable device that can detect and predict ep...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
S. Korea's SillaJen launches clinical trials in US for new anti-cancer drug
South Korean biotech company Sillajen Inc. has started recruiting patients for Phase 1 clinical trials in the US for an anti-cancer drug from a Swis...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem confirms diabetes drug Zemidapa's efficacy in phase 3 trials
LG Chem Ltd. announced in a disclosure on Monday that it had confirmed superior efficacy in phase 3 clinical trials for the combined administration ...
Dec 13, 2022 (Gmt+09:00)
-
Cloud computing
S.Korea's Bespin Global secures $107 mn from Middle East
South Korea's cloud management company Bespin Global said on Monday that it has secured 140 billion won ($107 million) in investment from e& Ent...
Dec 12, 2022 (Gmt+09:00)
-
Electric vehicles
Hyundai, Kia on course for record EV sales in Europe
Hyundai Motor Group, South Korea’s top carmaker, is on course for record electric vehicle sales in Europe, with its new models' expansion in t...
Dec 11, 2022 (Gmt+09:00)
-
Bio & Pharma
New drug developer Onconic Therapeutics raises $20 mn in Series B
South Korean drug developer Onconic Therapeutics, announced on Friday that it raised 26 billion won ($19.9 million) in Series B funding, with cumula...
Dec 09, 2022 (Gmt+09:00)
-
Capital raising
SK On attracts $1 billion in investment
SK On, the electric battery affiliate of Korea's petroleum, alternative energy and oil exploration corporation SK Innovation, has secured 1.3 trilli...
Dec 01, 2022 (Gmt+09:00)
-
Korean chipmakers
Shell-First: Samsung Foundry’s custom-tailored new operation strategy
As the contract chip manufacturing, or foundry, business is quickly emerging as the next battlefield for the world’s major chipmakers, The Korea...
Nov 30, 2022 (Gmt+09:00)
-
Economy
OECD cuts Korea's economic growth forecast for next year to 1.8%
The Organisation for Economic Development and Co-operation (OECD) has cut its forecast for South Korea's economic growth next year to 1.8%, down fro...
Nov 23, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins trial against Regeneron for US patent lawsuit over biosimilar
South Korean biopharmaceutical company Celltrion Inc. announced Friday that it won its first trial against New York-based biotech giant Regeneron Ph...
Nov 18, 2022 (Gmt+09:00)
-
Food & Beverage
South Korean burger franchise Lotteria looks to the US for expansion
South Korea’s fast food franchise Lotteria is planning to enter the United States, home to the world’s best-known burger franchises.&nbs...
Nov 15, 2022 (Gmt+09:00)
-
Retail
Korean retail brand F&F’s Chinese sales seen above $800 million
South Korean outdoor clothing retailer F&F Co. is expected to post 1.1 trillion won ($807 million) in sales revenue in China this year, emerging...
Nov 10, 2022 (Gmt+09:00)
-
Healthcare
KT adds partner to expand Vietnam digital healthcare biz
KT Corp., a major South Korean telecom operator, has teamed up with another local company to expand its digital healthcare business in Vietnam furth...
Nov 07, 2022 (Gmt+09:00)